A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors

NCT02145559 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
Lung Neoplasms
Cancer of Liver
Lymphoma
Cancer of Kidney

Interventions

DRUG: Metformin XR
DRUG: Delayed Metformin
DRUG: Sirolimus

Sponsor

University of Chicago